Aratana Inks $20M For Animal Health
Kansas City-based Aratana Therapeutics has raised $20 million in a Series A round led by MPM Capital and San Diego-based Avalon Ventures. Newly formed Aratana aims to adapt advances in human biopharmaceutical technology for animals care. MPM Capital has offices in Boston and San Francisco.
7 January 2011•2 mins read
